Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 340 M359 M389 M378 M376 M371 M 1.51 B Research & development 154 M160 M160 M165 M163 M163 M 651 M Operating income 39 M41 M23 M46 M56 M107 M 232 M Non-Operating Income, Total 30 M27 M28 M25 M23 M19 M 95 M Interest expense, net of interest capitalized 1 M1 M1 M1 M1 M0 3 M Non-Operating Income, excl. Interest Expenses -1 M-1 M-1 M-1 M-1 M0 -3 M Unusual income/expense 30 M27 M28 M25 M23 M19 M 95 M Pretax income 68 M67 M50 M70 M78 M126 M 324 M Equity in earnings —————— — Taxes 6 M07 M7 M4 M10 M 28 M Non-controlling/minority interest —————— — After tax other income/expense -1 M-3 M1 M-5 M-3 M-1 M -8 M Net income before discontinued operations 62 M67 M43 M63 M74 M116 M 296 M Discontinued operations —————— — Net income 62 M67 M43 M63 M74 M116 M 296 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 67 M71 M44 M65 M77 M121 M 307 M Basic earnings per share (Basic EPS) 0.360.380.240.350.420.67 1.68 Diluted earnings per share (Diluted EPS) 0.350.370.240.350.420.65 1.66 Average basic shares outstanding 174.17 M175.46 M176.52 M168.08 M168.44 M167.51 M — Diluted shares outstanding 181.75 M180.97 M178.4 M179.29 M177.7 M178.23 M — EBITDA 99 M105 M88 M197 M126 M— — EBIT 39 M41 M23 M46 M56 M107 M 232 M Cost of revenue 155 M168 M170 M168 M170 M164 M 672 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 60 M64 M65 M151 M70 M59 M 345 M